Bionova Capital

Bionova Capital is a healthcare-focused venture capital firm based in Lisbon, Portugal, established in 2015. It invests in seed and early-stage life science companies across Europe, with a focus on therapeutics, biotechnology, digital health, medical devices and related health technology. The firm typically makes minority investments of roughly €200,000 to €1,000,000 per project, supporting startups through early growth and scale. It is formed by shareholders of Hovione, a large Portuguese pharmaceutical company, linking Bionova Capital to a broader pharmaceutical and research background, though it operates as an independent investment firm. The approach emphasizes backing innovative ventures in Europe that aim to advance drugs, diagnostics and health tech from concept to market.